April 27, 2020 / 1:21 PM / a month ago

BRIEF-Aptose Presents Preliminary Clinical Data On CG-806

April 27 (Reuters) - Aptose Biosciences Inc:

* APTOSE PRESENTS PRELIMINARY CLINICAL DATA ON CG-806 AT AACR VIRTUAL ANNUAL MEETING 2020

* APTOSE BIOSCIENCES - FIRST-IN-HUMAN TESTS OF CG-806 ARE BEING CARRIED OUT IN PHASE 1A/B CLINICAL STUDY

* APTOSE BIOSCIENCES - NO DRUG-RELATED SEVERE ADVERSE EVENTS OR DOSE-LIMITING TOXICITY HAVE BEEN OBSERVED IN PATIENTS TO DATE IN STUDY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below